These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24731838)

  • 21. The intestinal microbiota in inflammatory bowel diseases.
    Sartor RB
    Nestle Nutr Inst Workshop Ser; 2014; 79():29-39. PubMed ID: 25227293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of non-inflammatory factors in intestinal fibrosis.
    Zhao JF; Ling FM; Li JR; Chen YD; Huang L; Zhu LR
    J Dig Dis; 2020 Jun; 21(6):315-318. PubMed ID: 32406603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
    Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
    Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinases in inflammatory bowel disease: an update.
    O'Sullivan S; Gilmer JF; Medina C
    Mediators Inflamm; 2015; 2015():964131. PubMed ID: 25948887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory Bowel Disease.
    Prog Drug Res; 2016; 71():117-22. PubMed ID: 26939275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.
    Kerman DH; Deshpande AR
    Postgrad Med; 2014 Jul; 126(4):7-19. PubMed ID: 25141239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel.
    Gonçalves P; Magro F; Martel F
    Inflamm Bowel Dis; 2015 Feb; 21(2):453-67. PubMed ID: 25248003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gut microbiota and IBD].
    Seksik P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S44-51. PubMed ID: 20889004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal microbiota and ulcerative colitis.
    Ohkusa T; Koido S
    J Infect Chemother; 2015 Nov; 21(11):761-8. PubMed ID: 26346678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Genetic and Epigenetic Regulation in Intestinal Fibrosis in Inflammatory Bowel Disease: A Descending Process or a Programmed Consequence?
    Jarmakiewicz-Czaja S; Sokal A; Ferenc K; Motyka E; Helma K; Filip R
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic modulation during intestinal fibrosis.
    Bos S; Laukens D
    J Dig Dis; 2020 Jun; 21(6):319-325. PubMed ID: 32406133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interaction between humans and intestinal bacteria as a determinant for intestinal health : intestinal microbiome and inflammatory bowel diseases].
    Haller D; Hörmannsperger G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Feb; 58(2):159-65. PubMed ID: 25566836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
    Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
    Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Multiple Faces of Integrin-ECM Interactions in Inflammatory Bowel Disease.
    Garlatti V; Lovisa S; Danese S; Vetrano S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathways.
    Rogler G; Biedermann L; Scharl M
    Swiss Med Wkly; 2018; 148():w14599. PubMed ID: 29566254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
    Verbeke KA; Boesmans L; Boets E
    Proc Nutr Soc; 2014 Nov; 73(4):490-7. PubMed ID: 24969143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
    Satokari R
    Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of heat shock protein 47 in intestinal fibrosis of experimental colitis.
    Kitamura H; Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Matsumura K; Takeda Y; Uza N; Nagata K; Chiba T
    Biochem Biophys Res Commun; 2011 Jan; 404(2):599-604. PubMed ID: 21144841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutrigenomics and nutrigenetics in inflammatory bowel diseases.
    Gruber L; Lichti P; Rath E; Haller D
    J Clin Gastroenterol; 2012 Oct; 46(9):735-47. PubMed ID: 22941427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.